Abstract: Crystalline forms of compound 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide, pharmaceutical compositions and the methods of preparation and the use thereof.

Abstract: Provided are an electrokinetic device and method for in-situ leaching of uranium, belonging to the technical field of in-situ leaching of uranium. The electrokinetic device for in-situ leaching of uranium includes an injection well, a pumping well, a positive electrode, a negative electrode, leaching solution, and a direct current power supply. Uranium ore is provided between the injection well and the pumping well, the negative electrode is arranged in the injection well, and the positive electrode is arranged in the pumping well. The leaching solution is injected from the injection well, flows through the uranium ore, and then is pumped from the pumping well for uranium extraction. The direct current power supply is respectively connected to the positive electrode and the negative electrode, and is configured to apply direct current between the positive electrode and the negative electrode to promote the pooling of uranium-carrying ions towards the pumping well.

Abstract: A device for processing images are provided. The device a support bar, a mounting housing mounted with a camera lens, and a connector configured to connect the support bar to the mounting housing. The mounting housing is integrally rotatable with the connector with respect to the support bar. The mounting housing may further be mounted with an ultrasonic probe and a lightening device. The ultrasonic probe is configured to monitor a predefined change, such as a change in an occupation state of a parking space, and the camera lens and the lightening device is controlled at least by the monitored change. When the ultrasonic probe monitors that a car is leaving or entering a parking space, the camera lens and the lightening may be switched on.

Abstract: The present disclosure relates to a device. The device includes a first camera which is rotatable around a first axis and a second camera which is rotatable around a second axis. The first axis is in a direction of the second axis.

Abstract: The present invention belongs to the pharmaceutical field, and provides crystalline forms, solvates and the crystalline forms thereof of the compound (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin-7-yl)ethyl)amino)pyrimidine-5-carbonitrile, and the pharmaceutical composi-tions comprising the same as well as the methods of preparing the same and the use thereof.

Abstract: The present invention relates to the salts of a compound and the crystalline forms thereof. More specifically, the present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound 4-chloro-3-(2-(2-((4-((3S,5R)-3,5-dimethylpiperazin-1-yl)phenyl)amino)pyrimidin-5-yl)ethyl)-5-methoxy-N- methylbenzamide and the crystalline forms thereof, the pharmaceutical compositions comprising the same as well as the methods for preparing the same and the use thereof.

Abstract: The present invention belongs to the pharmaceutical field, and provides crystalline forms, solvates and the crystalline forms thereof of the compound (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin-7-yl)ethyl)amino)pyrimidine-5-carbonitrile of the formula shown below, and the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Abstract: The present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound (S)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine and the crystalline forms thereof, the solvates and the crystalline forms thereof, the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Abstract: The present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound (S)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine and the crystalline forms thereof, the solvates and the crystalline forms thereof, the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Abstract: The present disclosure relates to a device. The device includes a first camera which is rotatable around a first axis and a second camera which is rotatable around a second axis. The first axis is in a direction of the second axis.

Abstract: A device for processing images are provided. The device a support bar, a mounting housing mounted with a camera lens, and a connector configured to connect the support bar to the mounting housing. The mounting housing is integrally rotatable with the connector with respect to the support bar. The mounting housing may further be mounted with an ultrasonic probe and a lightening device. The ultrasonic probe is configured to monitor a predefined change, such as a change in an occupation state of a parking space, and the camera lens and the lightening device is controlled at least by the monitored change. When the ultrasonic probe monitors that a car is leaving or entering a parking space, the camera lens and the lightening may be switched on.

Abstract: Crystalline forms of compound 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide, pharmaceutical compositions and the methods of preparation and the use thereof.

Abstract: A device for processing images are provided. The device a support bar, a mounting housing mounted with a camera lens, and a connector configured to connect the support bar to the mounting housing. The mounting housing is integrally rotatable with the connector with respect to the support bar. The mounting housing may further be mounted with an ultrasonic probe and a lightening device. The ultrasonic probe is configured to monitor a predefined change, such as a change in an occupation state of a parking space, and the camera lens and the lightening device is controlled at least by the monitored change. When the ultrasonic probe monitors that a car is leaving or entering a parking space, the camera lens and the lightening may be switched on.

Abstract: The present invention belongs to the pharmaceutical field, and provides crystalline forms, solvates and the crystalline forms thereof of the compound (S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin-7-yl)ethyl)amino)pyrimidine-5-carbonitrile, and the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Abstract: Crystalline forms of compound 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide, pharmaceutical compositions and the methods of preparation and the use thereof.

Abstract: The present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound (S)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-N-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine and the crystalline forms thereof, the solvates and the crystalline forms thereof, the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof.

Abstract: Embodiments of the present disclosure disclose a method and an apparatus. The apparatus includes interface circuitry and processing circuitry. The processing circuitry obtains attribute information of multimedia information associated with a multimedia provider. The attribute information includes website information of a website used to display the multimedia information and identifier (ID) information associated with the multimedia information. The processing circuitry generates a machine-readable identification code to be scanned by a user device of a user based on at least the website information. Based on the ID information, the processing circuitry obtains a first image corresponding to the multimedia information. The processing circuitry determines an image area in the first image in which the machine-readable identification code is to be inserted. The processing circuitry inserts the machine-readable identification code into the image area to generate a second image.

Abstract: A device for processing images are provided. The device a support bar, a mounting housing mounted with a camera lens, and a connector configured to connect the support bar to the mounting housing. The mounting housing is integrally rotatable with the connector with respect to the support bar. The mounting housing may further be mounted with an ultrasonic probe and a lightening device. The ultrasonic probe is configured to monitor a predefined change, such as a change in an occupation state of a parking space, and the camera lens and the lightening device is controlled at least by the monitored change. When the ultrasonic probe monitors that a car is leaving or entering a parking space, the camera lens and the lightening may be switched on.

Abstract: Crystalline forms of compound 6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide, pharmaceutical compositions and the methods of preparation and the use thereof.

Abstract: The present invention relates to the pharmaceutical field, provides novel crystalline forms, solvates and the crystalline forms thereof of compound 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide, pharmaceutical compositions, as well as the methods of preparation and the use thereof.